D.E. Shaw & Co’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
– Sell
-60,000
Closed -$849K – 3803
2014
Q4
$849K Hold
60,000
– – ﹤0.01% 2951
2014
Q3
$1.02M Hold
60,000
– – ﹤0.01% 2791
2014
Q2
$1.79M Sell
60,000
-14,460
-19% -$347K ﹤0.01% 2398
2014
Q1
$1.86M Hold
74,460
– – ﹤0.01% 2461
2013
Q4
$2.14M Hold
74,460
– – ﹤0.01% 2472
2013
Q3
$2.45M Buy
74,460
+24,820
+50% +$772K ﹤0.01% 2244
2013
Q2
$1.54M Buy
+49,640
New +$1.33M ﹤0.01% 2362

Other funds holding INVA

D.E. Shaw & Co's INVA Position: Q3 2026 in Review

D.E. Shaw & Co increased its Innoviva (INVA) stake by 160% in Q3 2026, buying an estimated $5.66M and bringing the position to 432,757 shares worth $9.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

D.E. Shaw & Co first reported a position in INVA in Q3 2013 and has held it in 53 quarters since. The position peaked at $34.1M in Q4 2018. 289 funds tracked by Wall St. Rank hold INVA as of Q3 2026.

  • D.E. Shaw & Co held 432,757 shares of Innoviva worth $9.18M as of Q3 2026.
  • D.E. Shaw & Co bought 266,502 Innoviva shares in Q3 2026, an estimated $5.66M.
  • Innoviva made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q3 2026, its #1881 holding.
  • D.E. Shaw & Co first reported a position in Innoviva in Q3 2013 and has held it in 53 quarters since.
  • D.E. Shaw & Co's Innoviva position peaked at $34.1M in Q4 2018.
  • 289 funds tracked by Wall St. Rank held Innoviva as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.